Search company, investor...


Seed VC | Alive

Total Raised


Last Raised

$180K | 6 yrs ago

About TeleMD

TeleMD uses artificial intelligence (AI) for cancer diagnostics and prognostication.

Headquarters Location

Presnenskaya nab., 10


Russian Federation

+7 495 649-13-09



Expert Collections containing TeleMD

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

TeleMD is included in 3 Expert Collections, including Artificial Intelligence.


Artificial Intelligence

10,958 items

Companies developing artificial intelligence solutions, including cross-industry applications, industry-specific products, and AI infrastructure solutions.


Digital Health

10,585 items

The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.


Oncology Tech

457 items

This collection includes companies applying technology to cancer care, diagnosis, and treatment. Examples include vendors offering cancer detection and diagnosis, oncology clinical decision support, real-world data, and AI oncology drug discovery.

Latest TeleMD News

Artificial intelligence for medical diagnostics gets VC backing

Aug 3, 2017

3 Aug '17 Primer Capital, a Russian VC fund focused on biomed, has invested more than $180,000 in a software platform by TeleMD, a domestic start-up that uses artificial intelligence (AI) for cancer diagnostics and prognostication, Firrma reported . The start-up is reported to have plans to use the money to fine-tune the platform’s image recognition functionality for cancer diagnostics, and also to make the solution scalable for medical specialists from across disciplines to be able to analyze heterogeneous medical data. Sergei Sorokin, the TeleMD project leader, is hoping his platform will soon be marketed as “both a cloud-based solution and a self-contained software product.” TeleMD is designed to enable physicians to diagnose and predict oncologic developments in complicated cases by analyzing medical images and other patient-specific data. With the solution, doctors may expect to be able to reach out to broader medical communities and get remote advice. TeleMD is reported to have developed its diagnostics criteria and algorithms in close collaboration with experts from the Moscow-based Russian Blokhin Research Center for Oncology and some other leading scientific hubs and clinical centers. Primer Capital has a notably long history of backing advanced biomed projects. Last year alone, for example, the VC fund supported TsSB Genomics, a genomics solutions developer, FK Laboratories developing anti-thrombosis drugs, and a range of other start-ups. COMMENT ON THIS STORY

TeleMD Frequently Asked Questions (FAQ)

  • Where is TeleMD's headquarters?

    TeleMD's headquarters is located at Presnenskaya nab., 10, Moscow.

  • What is TeleMD's latest funding round?

    TeleMD's latest funding round is Seed VC.

  • How much did TeleMD raise?

    TeleMD raised a total of $180K.

  • Who are the investors of TeleMD?

    Investors of TeleMD include Primer Capital.



CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.